IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

BML Capital Management, LLC

Q2 2026 Holdings

Filed 2026-08-07 | 18 holdings | $176.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics Inc(ACRS)COM00461U105$63.3M11,975,00036.0%
Atea Pharmaceuticals Inc(AVIR)COM04683R106$32.3M6,952,33018.4%
Engene Therapeutics Inc(ENGN)COM *A*29286X101$11.5M6,669,9086.6%
Kraft Heinz Co(KHC)COM500754106$11.0M465,0006.2%
Outset MED Inc(OM)COM NEW690145206$10.9M2,519,7016.2%
Carmax Inc(KMX)COM143130102$9.1M172,5005.2%
Tillys Inc(TLYS)CL A886885102$9.0M2,150,0005.1%
PMV Pharmaceuticals Inc(PMVP)COM69353Y103$7.1M5,330,0004.1%
Instil BIO Inc(TIL)COM NEW45783C200$5.0M645,6002.8%
Target Corp(TGT)COM87612E106$4.9M37,5002.8%
Oramed Pharmaceuticals Inc(ORMP)COM NEW68403P203$4.2M866,2692.4%
Janux Therapeutics Inc(JANX)COM47103J105$2.4M154,9611.4%
Pliant Therapeutics Inc(PLRX)COM729139105$1.8M1,546,1371.0%
Connect Biopharma Hldgs LTD(CNTB)SHSG23549101$1.4M573,2870.8%
Imagenebio Inc(IMA)COM45175G207$1.2M200,7300.7%
Walmart Inc(WMT)PutCOM931142103$386.1K3350.2%
Core Scientific Inc New(CORZ)PutCOM21874A106$298.0K8000.2%
Tesla Inc(TSLA)PutCOM88160R101$270.0K3750.2%